Literature DB >> 23465007

Varicella zoster virus in solid organ transplantation.

S A Pergam1, A P Limaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23465007      PMCID： PMC5331930          DOI： 10.1111/ajt.12107

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  88 in total

Review 1.  Immunization of pediatric solid organ transplant candidates and recipients.

Authors:  M Burroughs; A Moscona
Journal:  Clin Infect Dis       Date:  2000-06-13       Impact factor: 9.079

2.  Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Authors:  S L Furth; E K Sullivan; A M Neu; A Tejani; B A Fivush
Journal:  Pediatr Transplant       Date:  1997-08

3.  Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

Authors:  D Lowance; H H Neumayer; C M Legendre; J P Squifflet; J Kovarik; P J Brennan; D Norman; R Mendez; M R Keating; G L Coggon; A Crisp; I C Lee
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

4.  Fulminant hepatic failure due to varicella zoster in a heart transplant patient: successful liver transplant.

Authors:  Marlén Alvite-Canosa; María Jesús Paniagua-Martín; Julia Quintela-Fandiño; Alejandra Otero; María Generosa Crespo-Leiro
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

5.  The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Authors:  Rachel Civen; Sandra S Chaves; Aisha Jumaan; Han Wu; Laurene Mascola; Paul Gargiullo; Jane F Seward
Journal:  Pediatr Infect Dis J       Date:  2009-11       Impact factor: 2.129

6.  Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.

Authors:  Anita Arora; Natalia Mendoza; Julie Brantley; Barbara Yates; Lynn Dix; Stephen Tyring
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

7.  Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?

Authors:  Yusri A Taha; Mark Quinlivan; Fiona T Scott; Mary Leedham-Green; Khidir Hawrami; Janice M Thomas; Judith Breuer
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

Review 8.  Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.

Authors:  B M Watson; S A Piercy; S A Plotkin; S E Starr
Journal:  Pediatrics       Date:  1993-01       Impact factor: 7.124

9.  Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella.

Authors:  S Suga; T Yoshikawa; T Ozaki; Y Asano
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

Review 10.  Pharmacokinetics of acyclovir after intravenous and oral administration.

Authors:  P de Miranda; M R Blum
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790
View more
  14 in total

Review 1.  Infections after lung transplantation.

Authors:  Mario Nosotti; Paolo Tarsia; Letizia Corinna Morlacchi
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

3.  Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial.

Authors:  Ruanne V Barnabas; Jared M Baeten; Jairam R Lingappa; Katherine K Thomas; James P Hughes; Nelly R Mugo; Sinead Delany-Moretlwe; Glenda Gray; Helen Rees; Andrew Mujugira; Allan Ronald; Wendy Stevens; Saidi Kapiga; Anna Wald; Connie Celum
Journal:  J Infect Dis       Date:  2015-06-08       Impact factor: 5.226

4.  Infectious Complications After Liver Transplantation.

Authors:  Maria Del Pilar Hernandez; Paul Martin; Jacques Simkins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-11

Review 5.  Authors reply to letter to the editor considering "Ramsay Hunt Syndrome with multiple cranial neuropathy: a literature review".

Authors:  Saikrishna Ananthapadmanabhan; Dilshard Soodin; Niranjan Sritharan; Vanaja Sivapathasingam
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-13       Impact factor: 3.236

6.  Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis.

Authors:  Ioanna D Pavlopoulou; Stavroula Poulopoulou; Christina Melexopoulou; Ioanna Papazaharia; George Zavos; Ioannis N Boletis
Journal:  BMC Infect Dis       Date:  2015-07-24       Impact factor: 3.090

7.  Herpes Zoster in Kidney Transplant Recipients: Detection of VZV DNA in Blood During the Prodromal Phase.

Authors:  Anne Devin; Edith Renoult; Michel Roger; Marie-Josée Hébert
Journal:  Transplant Direct       Date:  2018-05-02

Review 8.  Recent advances in understanding and managing infectious diseases in solid organ transplant recipients.

Authors:  Claire Aguilar; Shahid Husain; Olivier Lortholary
Journal:  F1000Res       Date:  2018-05-24

Review 9.  Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.

Authors:  Lei Wang; Erik A M Verschuuren; Coretta C van Leer-Buter; Stephan J L Bakker; Anoek A E de Joode; Johanna Westra; Nicolaas A Bos
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

10. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.